The group behind the leading public exchange-traded fund (ETF) for the Canadian cannabis industry on Monday (June 18) updated its lineup of ETFs with exposure to cannabis stocks.

Horizons ETFs Management revealed plans to list futures contracts for the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) and to launch three new “inverse and inverse leveraged ETFs.”

According to the Globe and Mail, leveraged ETFs are also commonly known as double ETFs and seek to provide investors with “two or three times the return on their stated index.” However, these have a higher risk than the more traditional index.

Horizons said the futures contracts on HMMJ will start trading on Monday on the Montreal Exchange and will have quarterly expiration dates for January, March, June and September with an initial extension to a June 2019 expiry.

“For us, this further legitimizes Marijuana-equity investing and HMMJ as the key way to get broad index exposure to this rapidly growing sector,” said Steve Hawkins, president and co-CEO of Horizons ETFs.

Overview of the new proposed ETFs

The information for the three new proposed ETFs isn’t final, but as of Monday is listed as:

  • BetaPro Canadian Marijuana Companies 2x Daily Bull ETF (HMJU): Seeks daily investment results. Before established costs, this ETF will look to correspond two times the daily performance of the Solactive Canadian Marijuana Companies Index.
  • BetaPro Canadian Marijuana Companies -2x Daily Bear ETF (HMJD): This new ETF will also compare itself to the Solactive index but will seek to create two times the opposite of its daily performance.
  • BetaPro Canadian Marijuana Companies Inverse ETF (HMJI): Similarly HMJI will use the Solactive index as a comparison, except this ETF will seek to correspond one time the inverse of the daily performance of Solactive.

Hawkins said Horizons believes there is demand for a riskier option by way of leveraged ETFs that create “higher short-term returns.”

Horizons estimates HMJI and HMJD will carry a hedging cost between 10 and 25 percent per year of the aggregate notional exposure. This cost is credited to the high price of borrowing securities from cannabis companies.

“If used appropriately, inverse marijuana ETFs could be a potentially more liquid and easier way for investors to get short exposure to Canadian-listed marijuana stocks while limiting their risk to what they invested,” Hawkins cautioned.

Horizons plans to stick with the law when it comes to exposure to US stocks or even recreational Canadian stocks until cannabis becomes fully legal. On the changes needed for the ETFs to allow US exposure Horizons wrote:

Unless and until the US Congress amends the US Controlled Substances Act with respect to cannabis, there is a risk that federal authorities may enforce current U.S. federal law against businesses operating in the U.S. cannabis industry, which may adversely affect the market price of any constituent issuers that have exposure to the US cannabis industry, and therefore the value of a New ETF

Horizons explained that if a constituent from one of its indexes gets delisted from the Toronto Stock Exchange or TSX Venture because of breaching the guidelines from these TMX Group exchanges then it will also be removed from the index.

“Any security imbalances caused by material rebalances or trading halts can affect the marked-to-market value of the forward documents negatively on any given day in relation to the closing level of the underlying index,” Horizons wrote.

Horizons started the first ETF focused exclusively on cannabis stocks, HMMJ, which has some of the biggest licensed producers as its top holdings. So far in 2018 HMMJ has seen a 4.71-percent decline in value and is currently priced at C$18.54. In March, HMMJ added 10 more cannabis listings for the overall index, bringing it to a total of 40 stocks.

Horizons also launched an additional ETF in February, the Emerging Marijuana Growers Index ETF (AQN:HMJR), which has a focus on smaller-cap producers of cannabis.

“HMJR will exclusively invest in marijuana growers that, in our view, are well-positioned to take part in the global growth of the marijuana sector,” Hawkins said in a statement from the Aequitas NEO Exchange. HMJR is currently priced at $C8.25.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

World High Life Plc (“World High Life” or the “Company”)(AQSE:LIFE) (OTCQB:WRHLF), is pleased to announce that it has appointed H&P Advisory Limited (“Hannam & Partners”) as financial advisor to the Company with immediate effect

About Love Hemp

Keep reading... Show less

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:

Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.

Keep reading... Show less

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less